T Punga, R Le Panse, M Andersson, F Truffault, S Berrih‐Aknin, ... Annals of clinical and translational neurology 1 (1), 49-58, 2014. 93: 2014: Vitamin D deficiency in patients with …

Purpose: Optimizing the diagnostic utility of repetitive nerve stimulation in myasthenia gravis (MG) may include tailoring the examination to clinical phenotype. Therefore, we analyzed all …

Muscle-specific tyrosine kinase antibody-positive myasthenia gravis and Lambert-Eaton myasthenic syndrome are about 20 times less common. Several diagnostic methods are …

2012年11月28日 · The present study indicates that 8 weeks daily intake of 3 g of β-glucans significantly reduces total cholesterol, LDL, ApoA1 and ApoB in MG patients. β-glucans may …

Anna PUNGA, Professor of clinical neurophysiology | Cited by 1,837 | of Uppsala University, Uppsala (UU) | Read 112 publications | Contact Anna PUNGA

In the past 5–10 years, epidemiological studies worldwide suggest an incidence of acetylcholine receptor antibody-positive myasthenia gravis of up to 29 cases per 1 million people per year. …

2023年8月29日 · Studies of circulating miRNA profiles in Lrp4 or agrin antibody seropositive MG are still lacking. This review summarizes the present knowledge of circulating miRNAs in …

2011年1月24日 · Dr A. R. Rostedt Punga, *present address below. Present address: Institute of Neuroscience, Department of Clinical Neurophysiology, Uppsala University Hospital, 75185 …

As muscle involvement is strikingly selective in pathological conditions in which MuSK is targeted, including congenital myasthenic syndrome with MuSK mutation and MuSK antibody …

Punga et al. described distinct miRNA profiles in the subgroups of AChR+ MG and MuSK+ MG 17, 18, 19 as well as recently also in LOMG. 20 Furthermore, miR‐20b was found decreased …